ACOR Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: ACOR Shares Outstanding History and ACOR YTD Return |
ACOR Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: ACOR Shares Outstanding History and ACOR YTD Return |
ACOR Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-26.82% CAGR Mouse over chart for data details
|
ACOR Stock Price Chart |
About Acorda Therapeutics Inc |
Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Co. markets Inbrija (levodopa inhalation powder), which is approved for intermittent treatment of episodic motor fluctuations, also known as OFF periods, in people with Parkinson's disease treated with carbidopa/levodopa. Inbrija utilizes Co.'s ARCUS pulmonary delivery system, a technology platform designed to deliver medication through inhalation. Co. also markets Ampyra (dalfampridine) extended release tablets, 10 mg for improving walking in patients with multiple sclerosis. Ampyra is marketed as Fampyra outside the U.S. We show 56 historical shares outstanding datapoints in our ACOR shares outstanding history coverage, used to compute ACOR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ACOR market cap history over the course of time is important for investors interested in comparing ACOR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ACOR versus a peer is one thing; comparing ACOR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ACOR can fluctuate over the course of history. With this page we aim to empower investors researching ACOR by allowing them to research the ACOR market cap history. |
ACOR Current Stock Quote |
Free ACOR Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
ACOR Share Performance |
Market Cap Peers |
Acorda Therapeutics (ACOR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ACRS Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.